Related references
Note: Only part of the references are listed.The role of ceramides in selected brain pathologies: ischemia/hypoxia, Alzheimer disease
Halina Car et al.
POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ (2012)
Fingolimod Provides Long-Term Protection in Rodent Models of Cerebral Ischemia
Ying Wei et al.
ANNALS OF NEUROLOGY (2011)
Fingolimod modulates microglial activation to augment markers of remyelination
Samuel J. Jackson et al.
JOURNAL OF NEUROINFLAMMATION (2011)
Caspase-3 triggers early synaptic dysfunction in a mouse model of Alzheimer's disease
Marcello D'Amelio et al.
NATURE NEUROSCIENCE (2011)
FTY720 Reduces Post-Ischemic Brain Lymphocyte Influx but Does Not Improve Outcome in Permanent Murine Cerebral Ischemia
Arthur Liesz et al.
PLOS ONE (2011)
FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation
Ji Woong Choi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Lipid mediators in the nucleus: Their potential contribution to Alzheimer's disease
Akhlaq A. Farooqui et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2010)
Mechanism of Action of Oral Fingolimod (FTY720) in Multiple Sclerosis
Jerold Chun et al.
CLINICAL NEUROPHARMACOLOGY (2010)
Amyloid-β-induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks
Jorge J. Palop et al.
NATURE NEUROSCIENCE (2010)
Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis
Volker Brinkmann et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Deregulation of sphingolipid metabolism in Alzheimer's disease
Xingxuan He et al.
NEUROBIOLOGY OF AGING (2010)
Alzheimer's Disease Amyloid β-Protein and Synaptic Function
Tomas Ondrejcak et al.
NEUROMOLECULAR MEDICINE (2010)
REGULATION OF SYNAPTIC STRENGTH BY SPHINGOSINE 1-PHOSPHATE IN THE HIPPOCAMPUS
T. Kanno et al.
NEUROSCIENCE (2010)
Activation of Sphingosine 1-Phosphate Receptor-1 by FTY720 Is Neuroprotective After Ischemic Stroke in Rats
Yu Hasegawa et al.
STROKE (2010)
The interaction of beta-amyloid protein with cellular membranes stimulates its own production
Imke Peters et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2009)
Regulation of ceramide-induced neuronal death: Cell metabolism meets neurodegeneration
Gonzalo Arboleda et al.
BRAIN RESEARCH REVIEWS (2009)
Reassessing the amyloid cascade hypothesis of Alzheimer's disease
Sanjay W. Pimplikar
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2009)
Subcellular Origin of Sphingosine 1-Phosphate Is Essential for Its Toxic Effect in Lyase-deficient Neurons
Nadine Hagen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Accumulation of Fingolimod (FTY720) in Lymphoid Tissues Contributes to Prolonged Efficacy
Sven-Christian Sensken et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Beta-amyloid induced neuroinflammation: Regulation by natural and pharmacological compounds
M. T. Heneka
JOURNAL OF THE NEUROLOGICAL SCIENCES (2009)
New players on the center stage: Sphingosine 1-phosphate and its receptors as drug targets
Andrea Huwiler et al.
BIOCHEMICAL PHARMACOLOGY (2008)
Central nervous system-directed effects of FTY720 (fingolimod)
Veronique E. Miron et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2008)
Neurotoxic effect of oligomeric and fibrillar species of amyloid-beta peptide 1-42: Involvement of endoplasmic reticulum calcium release in oligomer-induced cell death
R. Resende et al.
NEUROSCIENCE (2008)
Brain sphingosine-1-phosphate receptors: Implication for FTY720 in the treatment of multiple sclerosis
Kumlesh K. Dev et al.
PHARMACOLOGY & THERAPEUTICS (2008)
Brain penetration of the oral immunomodulatory drug FTY720 and its phosphorylation in the central nervous system during experimental autoimmune encephalomyelitis: Consequences for mode of action in multiple sclerosis
Carolyn A. Foster et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Critical role for sphingosine kinase-1 in regulating survival of neuroblastoma cells exposed to amyloid-β peptide
Anne Gomez-Brouchet et al.
MOLECULAR PHARMACOLOGY (2007)
Involvement of sphingosine-1-phosphate in glutamate secretion in hippocampal neurons
Taketoshi Kajimoto et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Ceramide/sphingosine/sphingosine 1-phosphate metabolism on the cell surface and in the extracellular space
Motohiro Tani et al.
CELLULAR SIGNALLING (2007)
The immunosuppressant drug FTY720 inhibits cytosohc phospholipase A2 independently of sphingosine-1-phosphate receptors
Shawn G. Payne et al.
BLOOD (2007)
The metabolism and function of sphingolipids and glycosphingolipids
S. Lahiri et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2007)
Anastrozole improved testosterone-induced impairment acquisition of spatial learning and memory in the hippocampal CA1 region in adult male rats
Farshad Moradpour et al.
BEHAVIOURAL BRAIN RESEARCH (2006)
Soluble oligomers of amyloid-β peptide induce neuronal apoptosis by activating a cPLA2-dependent sphingomyelinase-ceramide pathway
Catherine Malaplate-Armand et al.
NEUROBIOLOGY OF DISEASE (2006)
FTY720, a new class of immunomodulator, inhibits lymphocyte egress from secondary lymphoid tissues and thymus by agonistic activity at sphingosine 1-phosphate receptors
K Chiba
PHARMACOLOGY & THERAPEUTICS (2005)
The immune modulator FTY720 inhibits sphingosine-1-phosphate lyase activity
P Bandhuvula et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease
RG Cutler et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Fibrillar amyloid-β peptides kill human primary neurons via NADPH oxidase-mediated activation of neutral sphingomyelinase -: Implications for Alzheimer's disease
A Jana et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Ceramide stabilizes β-site amyloid precursor protein-cleaving enzyme 1 and promotes amyloid β-peptide biogenesis (Withdrawn Publication. See vol. 298, 2022) (Withdrawn Publication. See vol. 298, 2022)
L Puglielli et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Sphingosine-1-phosphate inhibits acid sphingomyelinase and blocks apoptosis in macrophages
A Gómez-Muñoz et al.
FEBS LETTERS (2003)
Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer's disease: potential role in disease pathogenesis
XL Han et al.
JOURNAL OF NEUROCHEMISTRY (2002)
Sphingosine 1-phosphate, a key cell signaling molecule.
S Spiegel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Multiple caspases are involved in β-amyloid-induced neuronal apoptosis
JW Allen et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2001)
Correlation of β-amyloid aggregate size and hydrophobicity with decreased bilayer fluidity of model membranes
JJ Kremer et al.
BIOCHEMISTRY (2000)
Review:: Alzheimer's amyloid β-peptide-associated free radical oxidative stress and neurotoxicity
S Varadarajan et al.
JOURNAL OF STRUCTURAL BIOLOGY (2000)
Physiology and pathophysiology of sphingolipid metabolism and signaling
A Huwiler et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2000)